rs79913182
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_139318.5(KCNH5):c.2315A>G(p.Glu772Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000337 in 1,614,210 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_139318.5 missense
Scores
Clinical Significance
Conservation
Publications
- infantile-onset epilepsyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- developmental and epileptic encephalopathy 112Inheritance: AD Classification: STRONG Submitted by: G2P
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -13 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00173 AC: 263AN: 152198Hom.: 1 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000505 AC: 127AN: 251484 AF XY: 0.000375 show subpopulations
GnomAD4 exome AF: 0.000192 AC: 281AN: 1461894Hom.: 0 Cov.: 48 AF XY: 0.000179 AC XY: 130AN XY: 727248 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00173 AC: 263AN: 152316Hom.: 1 Cov.: 33 AF XY: 0.00170 AC XY: 127AN XY: 74492 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.2315A>G (p.E772G) alteration is located in exon 11 (coding exon 11) of the KCNH5 gene. This alteration results from a A to G substitution at nucleotide position 2315, causing the glutamic acid (E) at amino acid position 772 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Developmental and epileptic encephalopathy Benign:1
- -
not provided Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at